Reference
1. Larsen JN, Broge L, Jacobi H. Allergy immunotherapy: the future of allergy treatment. Drug discovery today. 2016;21(1):26-37.
2. Rapiejko P, Jurkiewicz D, Pietruszewska W, Zielnik-Jurkiewicz B, Woroń J, Lipiec A. Treatment strategy of allergic rhinitis in the face of modern world threats. Otolaryngologia polska = The Polish otolaryngology. 2018;72(2):1-12.
3. Tie K, Miller C, Zanation AM, Ebert CS, Jr. Subcutaneous Versus Sublingual Immunotherapy for Adults with Allergic Rhinitis: A Systematic Review with Meta-Analyses. The Laryngoscope. 2021.
4. Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: Allergic rhinitis. Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2015;152(1 Suppl):S1-43.
5. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. The Journal of allergy and clinical immunology. 1998;102(4 Pt 1):558-562.
6. Layhadi JA, Eguiluz-Gracia I, Shamji MH. Role of IL-35 in sublingual allergen immunotherapy. Current opinion in allergy and clinical immunology. 2019;19(1):12-17.
7. Kiel MA, Röder E, Gerth van Wijk R, Al MJ, Hop WC, Rutten-van Mölken MP. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. The Journal of allergy and clinical immunology. 2013;132(2):353-360.e352.
8. Chhiba KD, Patel GB, Vu THT, et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. The Journal of allergy and clinical immunology. 2020;146(2):307-314.e304.
9. Shaker MS, Oppenheimer J, Grayson M, et al. COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic. The journal of allergy and clinical immunology In practice. 2020;8(5):1477-1488.e1475.
10. Pfaar O, Demoly P, Gerth van Wijk R, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014;69(7):854-867.
11. Canonica GW, Baena-Cagnani CE, Bousquet J, et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy. 2007;62(3):317-324.
12. Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. The Journal of allergy and clinical immunology. 2017;140(4):950-958.
13. Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62(4):367-372.
14. Bousquet PJ, Combescure C, Klossek JM, Daurès JP, Bousquet J. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. The Journal of allergy and clinical immunology. 2009;123(6):1349-1354.
15. Poole CD, Bannister CA, Andreasen JN, Andersen JS, Currie CJ. Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy. Health and quality of life outcomes. 2014;12:99.
16. Calderón MA, Casale TB, Demoly P. Validation of Patient-Reported Outcomes for Clinical Trials in Allergic Rhinitis: A Systematic Review. The journal of allergy and clinical immunology In practice. 2019;7(5):1450-1461.e1456.
17. Clark J, Schall R. Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials. Allergy. 2007;62(9):1023-1028.
18. Juniper EF, Ståhl E, Doty RL, Simons FE, Allen DB, Howarth PH. Clinical outcomes and adverse effect monitoring in allergic rhinitis. The Journal of allergy and clinical immunology. 2005;115(3 Suppl 1):S390-413.
19. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 1991;21(1):77-83.
20. Kang Y, Liu S, Yang L, et al. Testing the Bidirectional Associations of Mobile Phone Addiction Behaviors With Mental Distress, Sleep Disturbances, and Sleep Patterns: A One-Year Prospective Study Among Chinese College Students. Frontiers in psychiatry. 2020;11:634.
21. Yuan L, Pan B, Wang W, Wang L, Zhang X, Gao Y. Prevalence and predictors of anxiety and depressive symptoms among patients diagnosed with oral cancer in China: a cross-sectional study. BMC psychiatry. 2020;20(1):394.
22. Liu P, Zeng F, Zhou G, et al. Alterations of the default mode network in functional dyspepsia patients: a resting-state fmri study. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2013;25(6):e382-388.
23. Peng M, Mo B, Liu Y, et al. Prevalence, risk factors and clinical correlates of depression in quarantined population during the COVID-19 outbreak. Journal of affective disorders. 2020;275:119-124.
24. Wu K, Wei X. Analysis of Psychological and Sleep Status and Exercise Rehabilitation of Front-Line Clinical Staff in the Fight Against COVID-19 in China. Medical science monitor basic research. 2020;26:e924085.
25. Cai X, Hu X, Ekumi IO, et al. Psychological Distress and Its Correlates Among COVID-19 Survivors During Early Convalescence Across Age Groups. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2020;28(10):1030-1039.
26. Zhang T, Yu GD, Gu P, Tang Q, Jin Y, He XC. [Evaluation and analysis of anxiety, depression and quality of life in vasomotor rhinitis]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery. 2020;55(8):769-773.
27. Liu S, Wu R, Li L, et al. The prevalence of anxiety and depression in Chinese asthma patients. PloS one. 2014;9(7):e103014.
28. Hao T, Youxiang M, Xiuyong D, Ruxiang Z, Jiao X. [Prevalence and psychopathological characteristics of anxiety and depression in patients with chronic rhinosinusitis before endoscopic sinus surgery]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery. 2015;50(3):210-214.
29. Li Y, Zhang H, Wang Y. Tai Chi Ameliorates Coronary Heart Disease by Affecting Serum Levels of miR-24 and miR-155. Frontiers in physiology. 2019;10:587.
30. Wang T, Li S, Jiang G, et al. Regional homogeneity changes in patients with primary insomnia. European radiology. 2016;26(5):1292-1300.
31. Guo Z, Tang HY, Li H, et al. The benefits of psychosocial interventions for cancer patients undergoing radiotherapy. Health and quality of life outcomes. 2013;11:121.
32. Pfaar O, Agache I, Bonini M, et al. COVID-19 pandemic and allergen immunotherapy - an EAACI survey. Allergy. 2021;10(2):111.
33. Klimek L, Jutel M, Akdis C, et al. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy. 2020;75(7):1546-1554.
34. WH. O. Infection prevention and control of epidemic-and pandemic prone acute respiratory infections in health care.
35. ECfDPa. C. Guidance for wearing and removing personal protective equipment in healthcare settings for the care of patients with suspected or confirmed COVID-19.
36. Lei L, Huang X, Zhang S, Yang J, Yang L, Xu M. Comparison of Prevalence and Associated Factors of Anxiety and Depression Among People Affected by versus People Unaffected by Quarantine During the COVID-19 Epidemic in Southwestern China. Medical science monitor : international medical journal of experimental and clinical research. 2020;26:e924609.
37. Pfaar O, Klimek L, Jutel M, et al. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper. Allergy. 2020.
38. Imai R, Hori H, Itoh M, et al. Inflammatory markers and their possible effects on cognitive function in women with posttraumatic stress disorder. Journal of psychiatric research. 2018;102:192-200.
39. Portnoy J, Waller M, Elliott T. Telemedicine in the Era of COVID-19. The journal of allergy and clinical immunology In practice. 2020;8(5):1489-1491.
40. Waibel KH, Bickel RA, Brown T. Outcomes From a Regional Synchronous Tele-Allergy Service. The journal of allergy and clinical immunology In practice. 2019;7(3):1017-1021.
41. Shaker MS, Mosnaim G, Oppenheimer J, Stukus D, Abrams EM, Greenhawt M. Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times. The journal of allergy and clinical immunology In practice. 2020;8(7):2310-2321.e2314.
42. Malipiero G, Paoletti G, Puggioni F, et al. An academic allergy unit during COVID-19 pandemic in Italy. The Journal of allergy and clinical immunology. 2020;146(1):227.
43. Malipiero G, Heffler E, Pelaia C, et al. Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model. Clinical and translational allergy. 2020;10:23.
44. Codispoti CD, Bandi S, Moy JN, Mahdavinia M. Running a virtual allergy division and training program in the time of COVID-19 pandemic. The Journal of allergy and clinical immunology. 2020;145(5):1357-1359.
45. Matricardi PM, Dramburg S, Alvarez-Perea A, et al. The role of mobile health technologies in allergy care: An EAACI position paper. Allergy. 2020;75(2):259-272.
46. Abi Fadel F, Al-Jaghbeer M, Kumar S, et al. The impact of the state of Ohio stay-at-home order on non-COVID-19 intensive care unit admissions and outcomes. Anaesthesiology intensive therapy. 2020;52(3):249-252.
47. Klimek L, Pfaar O, Worm M, et al. Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group(A) in cooperation with the Austrian ARIA Group(B), the Swiss ARIA Group(C), German Society for Applied Allergology (AEDA)(D), German Society for Allergology and Clinical Immunology (DGAKI)(E), Society for Pediatric Allergology (GPA)(F) in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHC(G) and the European Academy of Allergy and Clinical Immunology (EAACI)(H). Allergologie select. 2020;4:44-52.
48. Torlinski T. Initial hospital preparation and response to fight the COVID-19 pandemic, based on the British university hospital experience. Anaesthesiology intensive therapy. 2020;52(3):256-258.
49. Zieliński M, Wróblewski P, Kozielski J. Proposed practice guidelines for burn centres in the context of the SARS-CoV-2 pandemic. Anaesthesiology intensive therapy. 2020;52(3):245-248.
50. Jutel M, Brüggenjürgen B, Richter H, Vogelberg C. Real-world evidence of subcutaneous allergoid immunotherapy in house dust mite-induced allergic rhinitis and asthma. Allergy. 2020;75(8):2050-2058.